Skip to main content

Advertisement

SpringerLink
Log in

Avastin Exhibits Therapeutic Effects on Collagen-Induced Arthritis in Rat Model

  • Published:
Inflammation Aims and scope Submit manuscript

Abstract

Avastin is the monoclonal antibody for vascular endothelial growth factor (VEGF). This study aimed to investigate therapeutic effect of Avastin on type II collagen-induced arthritis. Type II chicken collagen was injected into the tails of Wistar rats, and 60 modeled female rats were randomly divided into three groups (n = 20): Avastin group, Etanercept group, and control group. Arthritis index and joint pad thickness were scored, and the pathology of back metapedes was analyzed. The results showed that compared to control group, the arthritis index, target-to-non-target ratio, synovial pathological injury index, serum levels of VEGF and tumor necrosis factor alpha, and VEGF staining were decreased significantly 14 days after Avastin or Etanercept treatment, but there were no significant differences between Avastin group and Etanercept group. These data provide evidence that Avastin exhibits similar effects to Etanercept to relieve rheumatoid arthritis in rat model and suggest that Avastin is a promising therapeutic agent for rheumatoid arthritis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Konisti, S., S. Kiriakidis, and E.M. Paleolog. 2012. Hypoxia—a key regulator of angiogenesis and inflammation in rheumatoid arthritis. Nat Rev Rheumatol 8: 153–162.

    Article  PubMed  CAS  Google Scholar 

  2. Szekanecz, Z., T. Besenyei, G. Paragh, et al. 2009. Angiogenesis in rheumatoid arthritis. Autoimmunity 42: 563–573.

    Article  PubMed  CAS  Google Scholar 

  3. Szekanecz, Z., and A.E. Koch. 2008. Targeting angiogenesis in rheumatoid arthritis. Curr Rheumatol Rev 4: 298–303.

    Article  PubMed  CAS  Google Scholar 

  4. Aaltonen, K.J., L.M. Virkki, A. Malmivaara, et al. 2012. Systematic review and meta-analysis of the efficacy and safety of existing TNF blocking agents in treatment of rheumatoid arthritis. PLoS One 7: e30275.

    Article  PubMed  CAS  Google Scholar 

  5. Alonso-Ruiz, A., J.I. Pijoan, E. Ansuategui, A. Urkaregi, M. Calabozo, and A. Quintana. 2008. Tumor necrosis factor alpha drugs in rheumatoid arthritis: systematic review and metaanalysis of efficacy and safety. BMC Musculoskelet Disord 9: 52.

    Article  PubMed  Google Scholar 

  6. Heinzerling, J.H., and S. Huerta. 2006. Bowel perforation from bevacizumab for the treatment of metastatic colon cancer: incidence, etiology, and management. Curr Surg 63: 334–337.

    Article  PubMed  Google Scholar 

  7. Luo, X., X. Zuo, X. Mo, Y. Zhou, and X. Xiao. 2011. Treatment with recombinant Hsp72 suppresses collagen-induced arthritis in mice. Inflammation 34: 432–439.

    Article  PubMed  CAS  Google Scholar 

  8. Palmblad, K., H. Erlandsson-Harris, K.J. Tracey, et al. 2001. Dynamics of early synovial cytokine expression in rodent collagen-induced arthritis: a therapeutic study using a macrophage-deactivating compound. Am J Pathol 158: 491–500.

    Article  PubMed  CAS  Google Scholar 

  9. Romas, E., N.A. Sims, D.K. Hards, et al. 2002. Osteoprotegerin reduces osteoclast numbers and prevents bone erosion in collagen-induced arthritis. Am J Pathol 161: 1419–1427.

    Article  PubMed  CAS  Google Scholar 

  10. Yoo, S.A., S.K. Kwok, and W.U. Kim. 2008. Proinflammatory role of vascular endothelial growth factor in the pathogenesis of rheumatoid arthritis: prospects for therapeutic intervention. Mediat Inflamm 2008: 129873.

    Article  Google Scholar 

  11. Paleolog, E.M. 2009. The vasculature in rheumatoid arthritis: cause or consequence? Int J Exp Pathol 90: 249–261.

    Article  PubMed  CAS  Google Scholar 

  12. Szekanecz, Z., T. Besenyei, A. Szentpétery, and A.E. Koch. 2010. Angiogenesis and vasculogenesis in rheumatoid arthritis. Curr Opin Rheumatol 22: 299–306.

    Article  PubMed  CAS  Google Scholar 

  13. Nagashima, M., H. Tanaka, H. Takahashi, et al. 2002. Study of the mechanism involved in angiogenesis and synovial cell proliferation in human synovial tissues of patients with rheumatoid arthritis using SCID mice. Lab Invest 82: 981–988.

    Article  PubMed  Google Scholar 

  14. Hashimoto, A., I.H. Tarner, R.M. Bohle, et al. 2007. Analysis of vascular gene expression in arthritic synovium by laser-mediated microdissection. Arthritis Rheum 56: 1094–105.

    Article  PubMed  CAS  Google Scholar 

  15. Clavel, G., N. Bessis, D. Lemeiter, et al. 2007. Angiogenesis markers (VEGF, soluble receptor of VEGF and angiopoietin-1) in very early arthritis and their association with inflammation and joint destruction. Clin Immunol 124: 158–164.

    Article  PubMed  CAS  Google Scholar 

  16. Thairu, N., S. Kiriakidis, P. Dawson, et al. 2011. Angiogenesis as a therapeutic target in arthritis in 2011: learning the lessons of the colorectal cancer experience. Angiogenesis 14: 223–234.

    Article  PubMed  CAS  Google Scholar 

  17. van Luijn, J.C., M. Danz, J.W. Bijlsma, F.W. Gribnau, and H.G. Leufkens. 2011. Post-approval trials of new medicines: widening use or deepening knowledge? Analysis of 10 years of Etanercept. Scand J Rheumatol 40: 183–191.

    Article  PubMed  Google Scholar 

  18. Cha, H.S., E.K. Bae, J.H. Koh, et al. 2007. Tumor necrosis factor-alpha induces vascular endothelial growth factor-C expression in rheumatoid synoviocytes. J Rheumatol 34: 16–19.

    PubMed  Google Scholar 

  19. Su, Z.F., G. Liu, S. Gupta, Z. Zhu, M. Rusckowski, and D.J. Hnatowich. 2002. In vitro and in vivo evaluation of a Technetium-99m-labeled cyclic RGD peptide as a specific marker of alpha(V)beta(3) integrin for tumor imaging. Bioconjug Chem 13: 561–570.

    Article  PubMed  CAS  Google Scholar 

Download references

Competing Interests

The authors declare that they have no competing interests.

Author information

Authors and Affiliations

  1. Department of Rheumatology, Beijing Chao-yang Hospital, Capital Medical University, Beijing, 100020, China

    Yong Wang & Yi Zheng

  2. Department of Rheumatology, The Affiliated Hospital of Inner Mongolia Medical University, Huhhot, 010050, China

    Yong Wang, Gula Da & Hongbin Li

Authors
  1. Yong Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gula Da
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hongbin Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yi Zheng
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Hongbin Li or Yi Zheng.

Additional information

Authors Yong Wang and Gula Da contributed equally.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, Y., Da, G., Li, H. et al. Avastin Exhibits Therapeutic Effects on Collagen-Induced Arthritis in Rat Model. Inflammation 36, 1460–1467 (2013). https://doi.org/10.1007/s10753-013-9687-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10753-013-9687-y

KEY WORDS

Search

Navigation